Enanta Pharmaceuticals, Inc. ( ENTA) - Key Metrics

ENTA Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q3 $0.49 -$0.67 -$0.34 -$0.34
2026Q2 $0.59 -$0.45 -$0.25 -$0.25
2026Q1 $0.65 -$0.42 -$0.41 -$0.41
2025Q4 $0.71 -$0.87 -$0.30 -$0.37
2025Q3 $0.86 -$0.86 $0.82 $0.81

ENTA Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q3 0% -5.44
2026Q2 0% -7.02
2026Q1 0% -9.39
2025Q4 0% -3.44
2025Q3 0% -2.20

ENTA

Price: $12.83

52 week price:
6.45
17.15

Earnings Per Share: -2.42 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 3045

Ebitda: 15.9 million

Market Capitalization: 383.3 million

Links: